A Role for Histone H2B Variants in Endocrine-Resistant Breast Cancer

Acquired resistance to aromatase inhibitors (AIs) remains a major clinical problem in the treatment of estrogen receptor-positive (ER+) breast cancer. We and others have previously reported widespread changes in DNA methylation using breast cancer cell line models of endocrine resistance. Here, we s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Horm Cancer
Main Authors: Nayak, Shweta R, Harrington, Emily, Boone, David, Hartmaier, Ryan, Chen, Jian, Pathiraja, Thushangi N., Cooper, Kristine L., Fine, Jeffrey L., Sanfilippo, Joseph, Davidson, Nancy E., Lee, Adrian V., Dabbs, David, Oesterreich, Steffi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2015
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4807402/
https://ncbi.nlm.nih.gov/pubmed/26113056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-015-0230-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados